Lucas Bruce 4
4 · Slide Insurance Holdings, Inc. · Filed May 19, 2026
Research Summary
AI-generated summary of this filing
Slide Insurance (SLDE) CEO Lucas Bruce Sells Shares
What Happened
- Lucas Bruce, CEO of Slide Insurance Holdings, sold a total of 997,881 shares in three open-market transactions: 269,881 shares on 2026-05-15 at a weighted average of $18.84 ($5,084,558), 455,000 shares on 2026-05-18 at $19.06 ($8,672,300), and 273,000 shares on 2026-05-19 at $18.97 ($5,178,810). Aggregate proceeds were approximately $18.94 million. These were sales (not purchases) executed pursuant to a pre-established 10b5-1 trading plan.
Key Details
- Transaction dates and amounts:
- May 15, 2026 — 269,881 shs @ $18.84 (≈ $5.08M)
- May 18, 2026 — 455,000 shs @ $19.06 (≈ $8.67M)
- May 19, 2026 — 273,000 shs @ $18.97 (≈ $5.18M)
- Price range across reported sales: $18.75 to $19.27 per share (weighted averages by tranche reported; the filer offered to provide per-price breakdown on request).
- Reported as sold under a 10b5-1 trading plan adopted Nov 21, 2025 (footnote F1) — indicates pre-arranged sales rather than ad-hoc insider trades.
- Holdings/beneficial ownership: several reported holdings are held through entities and trusts (IIM Holdings II, LLC; Ava Cloonen and Emma Cloonen Irrevocable Trusts) and the reporting person disclaims beneficial ownership of those shares except to the extent of pecuniary interest (see footnotes F3, F9, F10). The excerpt provided does not state the total shares Lucas Bruce beneficially owned after these transactions.
- Spousal activity: footnote F7 notes the reporting person’s spouse sold 98,692 shares between May 15–19, 2026 under a 10b5-1 plan.
- Filing: Form 4 filed May 19, 2026 for trades between May 15–19, 2026; no indication in the filing excerpt that the report was late.
Context
- These are routine insider sales executed under a 10b5-1 plan, which is a pre-arranged trading program that can provide an affirmative defense to insider trading claims when properly adopted. Sales do not necessarily indicate management sentiment about company prospects. Purchases generally carry more interpretive weight for bullish signals; this filing documents sizeable, pre-planned dispositions by the CEO.
Insider Transaction Report
Form 4
Lucas Bruce
DirectorChief Executive Officer10% Owner
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-05-15$18.84/sh−269,881$5,084,558→ 35,884,165 total(indirect: By LLC) - Sale
Common Stock
[F1][F4][F3]2026-05-18$19.06/sh−455,000$8,672,300→ 35,429,165 total(indirect: By LLC) - Sale
Common Stock
[F1][F5][F3]2026-05-19$18.97/sh−273,000$5,178,810→ 35,156,165 total(indirect: By LLC)
Holdings
- 1,151,445
Common Stock
- 220,000(indirect: By Spouse)
Common Stock
[F6] - 1,183,300(indirect: By Spouse)
Common Stock
[F7][F8] - 1,925,000(indirect: By Trust)
Common Stock
[F9] - 1,925,000(indirect: By Trust)
Common Stock
[F10]
Footnotes (10)
- [F1]Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2025.
- [F10]Represent shares held through the Ava Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F2]Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.75 to $19.02 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F3]The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F4]Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.90 to $19.27 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F5]Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.75 to $19.07 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- [F6]Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F7]The amount shown reflects the amount owned by the Reporting Person's spouse after the sale of 98,692 shares of common stock between May 15-19, 2026, pursuant to a 10b5-1 trading plan, at prices ranging from $18.75 to $19.27 per share.
- [F8]Represent shares of common stock beneficially owned by the Reporting Person's spouse through Securus Risk Management LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F9]Represent shares held through the Emma Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Signature
/s/ Andy Omiridis, Attorney-in-Fact for Bruce Lucas|2026-05-19